Literature DB >> 18846331

Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism.

Fancong Kong1, Zhichao Chen, Qiubai Li, Xiaolong Tian, Juan Zhao, Ke Yu, Yong You, Ping Zou.   

Abstract

The inhibitory effects of parthenolide (PTL) on angiogenesis induced by multiple myeloma (MM) cells in vitro and the mechanism were investigated. Human MM line RPMI8226 cells were cultured in vitro. The effects of MM culture supernatant on the migration and tubule formation ability of human umbilical vein endothelial cells (HUVECs) treated with PTL were observed. By using Western blot, the expression of p65 and IkappaB-alpha in MM cells was detected. RT-PCR was used to assay the expression of VEGF, IL-6, MMP2 and MMP9 mRNA in MM cells. ELISA was used to measure the levels of VEGF and IL-6 in MM cell culture supernatant. The expression of MMP2 and MMP9 in MM cells was examined by immunohistochemistry. (1) In 3.5, 5.0, 7.5 and 10 micromol/L PTL groups the number of migrated cells was 310 +/- 56, 207 +/- 28, 127 +/- 21 and 49 +/- 10 respectively, which was significantly different from that in positive control group (598 +/- 47) (P<0.01). In 3.5 and 5.0 micromol/L PTL groups the areas of capillary-like structures were 0.092 +/- 0.003 and 0.063 +/- 0.002 mm2, significantly less than in positive control group (0.262 +/- 0.012 mm2) (P<0.01), but in 7.5 and 10 micromol/L PTL groups no capillary-like structures were found; (2) After treatment with different concentrations of PTL for 48 h, the expression of p65 protein was gradually decreased, while that of IkappaB-alpha was gradually enhanced with the increased concentration of PTL; (3) After treatment with 3.5, 5.0, 7.5 and 10 micromol/L PTL for 48 h, the VEGF levels in the supernatant were 2373.4 +/- 392.2, 1982.3 +/- 293.3, 1247.0 +/- 338.4 and 936.5+/-168.5 pg/mL respectively, significantly different from those in positive control group (2729 +/- 440.0 pg/mL) (P<0.05). After treatment with 7.5 and 10 micromol/L PTL, the IL-6 levels in the culture supernatant were 59.6 +/- 2.8 and 41.4 +/- 9.8 pg/mL respectively, significantly lower than in positive control group (1287.3 +/- 43.5 pg/mL) (P<0.05); (4) RT-PCR revealed that PTL could significantly inhibit the expression of VEGF and IL-6 mRNA in MM cells, but not influence the expression of MMP2 and MMP9 mRNA.; (5) Immunohistochemistry indicated that PTL had no significant effects on the expression of MMP2 and MMP9 protein in MM cells. It was concluded that the abilities of the culture supernatant of MM cells treated with PTL to induce endothelial cells migration and tubule formation were significantly reduced, suggesting PTL could obviously inhibit the angiogenesis induced by MM cells. PTL could decrease NF-kappaB activity and significantly suppress the expression of VEGF and IL-6 mRNA and protein, which might contribute to the mechanism by which PTL inhibited the angiogenesis induced by MM cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846331     DOI: 10.1007/s11596-008-0508-8

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  21 in total

1.  Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.

Authors:  G Martinelli; C Terragna; E Zamagni; S Ronconi; P Tosi; R M Lemoli; G Bandini; M R Motta; N Testoni; M Amabile; E Ottaviani; N Vianelli; A de Vivo; A Gozzetti; S Tura; M Cavo
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

2.  [Proliferation inhibiting and apoptosis inducing effects of parthenolide on human multiple myeloma cells].

Authors:  Zhi-chao Chen; Qiu-bai Li; Jing Shao; Jian Lü; Yong You; Zhao-dong Zhong; Ping Zou
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2006-07-25

3.  Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy.

Authors:  R M Lemoli; G Martinelli; E Zamagni; M R Motta; S Rizzi; C Terragna; R Rondelli; S Ronconi; A Curti; F Bonifazi; S Tura; M Cavo
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

4.  Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma.

Authors:  M Cavo; C Terragna; G Martinelli; S Ronconi; E Zamagni; P Tosi; R M Lemoli; M Benni; G Pagliani; G Bandini; S Tura
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

5.  Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.

Authors:  B Dankbar; T Padró; R Leo; B Feldmann; M Kropff; R M Mesters; H Serve; W E Berdel; J Kienast
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

6.  Matrilysin is associated with progression of colorectal tumor.

Authors:  T Ishikawa; Y Ichikawa; M Mitsuhashi; N Momiyama; T Chishima; K Tanaka; H Yamaoka; K Miyazakic; Y Nagashima; T Akitaya; H Shimada
Journal:  Cancer Lett       Date:  1996-10-01       Impact factor: 8.679

7.  Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells.

Authors:  Siyuan Zhang; Zhong-Ning Lin; Cheng-Feng Yang; Xianglin Shi; Choon-Nam Ong; Han-Ming Shen
Journal:  Carcinogenesis       Date:  2004-07-15       Impact factor: 4.944

8.  Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.

Authors:  W T Bellamy; L Richter; Y Frutiger; T M Grogan
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

9.  Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide.

Authors:  Jing Wen; Kyung-Ran You; So-Youn Lee; Chang-Ho Song; Dae-Ghon Kim
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

10.  Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.

Authors:  Yen-Kim Won; Choon-Nam Ong; Xianglin Shi; Han-Ming Shen
Journal:  Carcinogenesis       Date:  2004-03-19       Impact factor: 4.944

View more
  3 in total

1.  Inhibitory effects of parthenolide on the activity of NF-κB in multiple myeloma via targeting TRAF6.

Authors:  Fan-Cong Kong; Jing-Qiong Zhang; Chen Zeng; Wen-Lan Chen; Wen-Xiang Ren; Guo-Xin Yan; Hong-Xiang Wang; Qiu-Bai Li; Zhi-Chao Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF.

Authors:  Bo Tian; Yuhang Xiao; Junliang Ma; Wei Ou; Hui Wang; Jie Wu; Jinming Tang; Baihua Zhang; Xiaojuan Liao; Desong Yang; Zhining Wu; Xu Li; Yong Zhou; Min Su; Wenxiang Wang
Journal:  Onco Targets Ther       Date:  2020-07-29       Impact factor: 4.147

3.  Parthenolide induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits FAK-mediated cell invasion.

Authors:  Sang Won Kwak; Eon Sub Park; Chung Soo Lee
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.